Literature DB >> 1419638

Lack of prognostic significance of DNA ploidy and S phase fraction in breast cancer.

P D Stanton1, T G Cooke, S J Oakes, J Winstanley, S Holt, W D George, G D Murray.   

Abstract

DNA Ploidy and S phase fraction (SPF) were measured in Stage I and II breast cancers from patients with at least 8 years of follow-up, to assess the prognostic significance of these data. Disaggregated sections of formalin-fixed, paraffin-embedded tumour were analysed by flow cytometry. SPF was calculated using a rectangular model of S phase, after subtraction of background debris using an exponential model. 64% of tumours were DNA aneuploid. The median SPF was 4.5% for DNA diploid, and 10.9% for DNA aneuploid tumours. There were small reductions in survival at 10 years for DNA aneuploid tumours, and for tumours with above median SPF, but these were not statistically significant. The relative hazard for DNA aneuploid tumours was 1.20 (95% CI 0.81-1.76), and for high SPF was 1.31 (95% CI 0.87-1.98). Neither factor was statistically correlated with survival in multivariate analysis. Technical and theoretical factors limit the accuracy and reproducibility of flow cytometric data, and may explain the lack of prognostic information given.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1419638      PMCID: PMC1977991          DOI: 10.1038/bjc.1992.387

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  13 in total

1.  Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry.

Authors:  G M Clark; L G Dressler; M A Owens; G Pounds; T Oldaker; W L McGuire
Journal:  N Engl J Med       Date:  1989-03-09       Impact factor: 91.245

Review 2.  Ploidy, proliferative activity and prognosis. DNA flow cytometry of solid tumors.

Authors:  D E Merkel; W L McGuire
Journal:  Cancer       Date:  1990-03-01       Impact factor: 6.860

3.  Comparison of fresh and paraffin-embedded tissue as starting material for DNA flow cytometry and evaluation of intratumor heterogeneity.

Authors:  O P Kallioniemi
Journal:  Cytometry       Date:  1988-03

Review 4.  Ploidy analysis and S-phase fraction determination by flow cytometry of invasive adenocarcinomas of the breast.

Authors:  H F Frierson
Journal:  Am J Surg Pathol       Date:  1991-04       Impact factor: 6.394

5.  Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer.

Authors:  D W Hedley; C A Rugg; R D Gelber
Journal:  Cancer Res       Date:  1987-09-01       Impact factor: 12.701

6.  Flow cytometric determination of breast tumor heterogeneity.

Authors:  J E Fuhr; A Frye; A A Kattine; S Van Meter
Journal:  Cancer       Date:  1991-03-01       Impact factor: 6.860

7.  Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance.

Authors:  D W Hedley; M L Friedlander; I W Taylor
Journal:  Cytometry       Date:  1985-07

8.  Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.

Authors:  D W Hedley; M L Friedlander; I W Taylor; C A Rugg; E A Musgrove
Journal:  J Histochem Cytochem       Date:  1983-11       Impact factor: 2.479

9.  DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04.

Authors:  B Fisher; N Gunduz; J Costantino; E R Fisher; C Redmond; E P Mamounas; R Siderits
Journal:  Cancer       Date:  1991-10-01       Impact factor: 6.860

10.  The prognostic significance of nuclear DNA content in invasive breast cancer--a study with long-term follow-up.

Authors:  S Toikkanen; H Joensuu; P Klemi
Journal:  Br J Cancer       Date:  1989-11       Impact factor: 7.640

View more
  10 in total

1.  Biological indices in the assessment of breast cancer.

Authors:  A S Leong; A K Lee
Journal:  Clin Mol Pathol       Date:  1995-10

2.  Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.

Authors:  A E Pinto; S André; J Soares
Journal:  J Clin Pathol       Date:  1999-08       Impact factor: 3.411

3.  Analysis of DNA and morphometry in breast carcinoma.

Authors:  M Aubele; G Auer; H Höfler
Journal:  Histochem Cell Biol       Date:  1996-08       Impact factor: 4.304

4.  The prognostic significance of DNA ploidy in adenocarcinomas of the esophagogastric junction.

Authors:  M Sarbia; G Molsberger; R Willers; O Horstmann; C Schroders; R Porschen; E Gabbert H
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

5.  DNA ploidy analyses in 218 consecutive Pakistani breast cancer patients: does it add anything?

Authors:  E Khan; Z Mapara; S Khan; N Arshad; T Siddiqui; S Pervez
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

6.  Relation between deletion of chromosome 1p36 and DNA ploidy in breast carcinoma: an interphase cytogenetic study.

Authors:  F Farabegoli; N Baldini; D Santini; C Ceccarelli; M Taffurelli; D Treré; M Derenzini
Journal:  Clin Mol Pathol       Date:  1996-04

7.  The prognostic significance of determining DNA content in breast cancer by DNA image cytometry: the role of high grade aneuploidy in node negative breast cancer.

Authors:  Selma Yildirim-Assaf; Alexandra Coumbos; Werner Hopfenmüller; Hans-Dieter Foss; Harald Stein; Wolfgang Kühn
Journal:  J Clin Pathol       Date:  2007-06       Impact factor: 3.411

8.  Prognostic value of the S-phase fraction of breast cancer.

Authors:  Y Remvikos
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640

9.  The prognostic significance of DNA flow cytometry in breast cancer: results from 881 patients treated in a single centre.

Authors:  R S Camplejohn; C M Ash; C E Gillett; B Raikundalia; D M Barnes; W M Gregory; M A Richards; R R Millis
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640

10.  Outcome and human epidermal growth factor receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated by bromodeoxyuridine labelling.

Authors:  Sian M Tovey; Caroline J Witton; John M S Bartlett; Peter D Stanton; Jonathan R Reeves; Timothy G Cooke
Journal:  Breast Cancer Res       Date:  2004-03-23       Impact factor: 6.466

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.